Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on Marketwise, Maintains $6 Price Target By Benzinga Newsdesk March 13, 8:20 AM JMP Securities analyst Devin Ryan reiterates Marketwise (NASDAQ:MKTW) with a Market Outperform and maintains $6 price target. MKTW
Read More 1 minute read Analyst Ratings News Price Target Reiteration JMP Securities Reiterates Market Outperform on LPL Finl Hldgs, Maintains $290 Price Target By Benzinga Newsdesk March 13, 8:18 AM JMP Securities analyst Devin Ryan reiterates LPL Finl Hldgs (NASDAQ:LPLA) with a Market Outperform and maintains $290 price target. LPLA
Read More 1 minute read Analyst Ratings News Price Target Reiteration Mizuho Reiterates Neutral on ACADIA Pharmaceuticals, Maintains $19 Price Target By Benzinga Newsdesk March 13, 8:12 AM Mizuho analyst Uy Ear reiterates ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Neutral and maintains $19 price target. ACAD
Read More 2 minute read Analyst Ratings What 13 Analyst Ratings Have To Say About Moderna By Benzinga Insights March 13, 8:01 AM Over the past 3 months, 13 analysts have published their opinion on Moderna (NASDAQ:MRNA) stock. These analysts are… MRNA
Read More 1 minute read Analyst Ratings What 10 Analyst Ratings Have To Say About Amedisys By Benzinga Insights March 13, 8:01 AM Within the last quarter, Amedisys (NASDAQ:AMED) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish… AMED
Read More 2 minute read Analyst Ratings Where JPMorgan Chase Stands With Analysts By Benzinga Insights March 13, 8:01 AM Within the last quarter, JPMorgan Chase (NYSE:JPM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat… JPM
Read More 2 minute read Analyst Ratings Expert Ratings for Truist Finl By Benzinga Insights March 13, 8:00 AM Within the last quarter, Truist Finl (NYSE:TFC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat… TFC
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Oatly Group, Maintains $7 Price Target By Benzinga Newsdesk March 13, 7:57 AM RBC Capital analyst Nik Modi reiterates Oatly Group (NASDAQ:OTLY) with a Outperform and maintains $7 price target. OTLY
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Outperform on Adobe, Maintains $395 Price Target By Benzinga Newsdesk March 13, 7:55 AM RBC Capital analyst Matthew Hedberg reiterates Adobe (NASDAQ:ADBE) with a Outperform and maintains $395 price target. ADBE
Read More 1 minute read Analyst Ratings News Price Target Reiteration RBC Capital Reiterates Sector Perform on UiPath, Maintains $15 Price Target By Benzinga Newsdesk March 13, 7:53 AM RBC Capital analyst Matthew Hedberg reiterates UiPath (NYSE:PATH) with a Sector Perform and maintains $15 price target. PATH